Invesco RAFI US 1500 Smal... (PRFZ)
NasdaqGM: PRFZ
· Echtzeitkurs · USD
56.61
-0.19 (-0.33%)
Zum Schluss: Aug 17, 2026, 3:59 PM
Invesco RAFI US 1500 Small-Mid ETF (PRFZ) ETF Price, Holdings & Analysis
-0.33% (1D)
| Geld | 55.48 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 2.76 Mrd |
| NAV | 56.81 |
| Beta | 1.15 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 20.85 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Sep 20, 2006 |
| Brief | 55.56 |
| Volumen | 63,169 |
| Ø Vol. (20D) | 97,511 |
| Eröffnung | 56.68 |
| Vortagesschluss | 56.80 |
| Tagesspanne | 56.52 - 56.72 |
| 52-Wk Range | 42.51 - 56.84 |
| Positionen | k.A. |
| Kostenquote | 0.34% |
Über PRFZ
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index is composed of approximately 1,500 common stocks and is designed to track the performance of small- and medium-sized U.S. companies based on the following four fundamental measures of firm size: book value, cash flow, sales and dividends.
Anlageklasse Equity
Tickersymbol PRFZ
Auflagedatum Sep 20, 2006
Anbieter Invesco
Website Fonds-Homepage
Börse NasdaqGM
Top Sektoren
| Sektor | Gewicht % |
|---|---|
| Technology | 18.26% |
| Healthcare | 18.03% |
| Industrials | 15.23% |
| Financial Services | 14.56% |
| Consumer Cyclical | 11.50% |
Top 10 Positionen 3.81% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Par Pacific Holdings... | PARR | 0.46% |
| Ati Inc | ATI | 0.42% |
| Roivant Sciences Ltd... | ROIV | 0.41% |
| Revolution Medicines... | RVMD | 0.40% |
| Iridium Communicatio... | IRDM | 0.38% |
| Enova International ... | ENVA | 0.35% |
| Ttm Technologies Inc | TTMI | 0.35% |
| Maxlinear Inc | MXL | 0.35% |
| Sharkninja Inc | SN | 0.35% |
| Bio-techne Corp | TECH | 0.34% |
Dividenden Dividendenrendite 0.76%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 22, 2026 | $0.0990 | k.A. |
| Mar 23, 2026 | $0.1020 | k.A. |
| Dec 22, 2025 | $0.1140 | k.A. |
| Sep 22, 2025 | $0.1150 | k.A. |
| Jun 23, 2025 | $0.1050 | k.A. |
